Company
iSpecimen Inc.
iSpecimen operates an online marketplace connecting life science researchers with healthcare providers who supply human biospecimens for medical research.
iSpecimen Inc. is a publicly traded company. It trades under the ticker ISPC. Leadership tracked by CEOInsider includes Shahin Behroyan (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage of iSpecimen has focused on the company's completion of a large-scale international cancer research order, with samples delivered within three weeks, alongside financial developments including the closing of a $5 million public offering of common stock and pre-funded warrants. The company also faced a negative earnings report that missed expectations and resulted in a decline in share price, though coverage has highlighted the company's balance sheet strength and operational capabilities in biospecimen procurement and matching.
Summarized from the headlines in the sidebar; see each source for the full story.